Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+239.4%
5Y CAGR+73.0%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+239.4%/yr
vs -39.7%/yr prior
5Y CAGR
+73.0%/yr
Recent acceleration
Acceleration
+279.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
15.5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 2144.10% |
| 2024 | -106.08% |
| 2023 | -11.04% |
| 2022 | 54.83% |
| 2021 | -2.60% |
| 2020 | 138.51% |
| 2019 | 88.55% |
| 2018 | 415.36% |
| 2017 | 1140.37% |
| 2016 | 102.12% |